1756-9966

Journal of Experimental & Clinical Cancer Research

Springer (Biomed Central Ltd.)

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 3494 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact3494 DOIs
2

Add abstracts to 1815 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact1815 DOIs
3

Add license metadata to 998 records

License metadata tells indexers and readers how each article may be reused.

Low impact998 DOIs

DOIs for this ISSN

Showing the top 5 of 4538 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Metabolic reprogramming: the emerging concept and associated… (10.1186/s13046-015-0221-y)
Abstract ORCID License
208.69 605
2 Exosomal transfer of tumor-associated macrophage-derived miR… (10.1186/s13046-017-0528-y)
Abstract ORCID License
203.89 522
3 Cell cycle checkpoint in cancer: a therapeutically targetabl… (10.1186/s13046-016-0433-9)
Abstract ORCID License
184.34 286
4 circGFRA1 and GFRA1 act as ceRNAs in triple negative breast… (10.1186/s13046-017-0614-1)
Abstract ORCID License
181.99 266
5 TIMP1 is a prognostic marker for the progression and metasta… (10.1186/s13046-016-0427-7)
Abstract ORCID License
180.49 254
6 Targeting autophagy to sensitive glioma to temozolomide trea… (10.1186/s13046-016-0303-5)
Abstract ORCID License
179.71 248
7 Notch1 signaling in melanoma cells promoted tumor-induced im… (10.1186/s13046-017-0664-4)
Abstract ORCID License
178.65 240
8 Peritumoural neutrophils negatively regulate adaptive immuni… (10.1186/s13046-015-0256-0)
Abstract ORCID License
177.13 229
9 Autophagy promotes metastasis and glycolysis by upregulating… (10.1186/s13046-018-0673-y)
Abstract ORCID License
169.86 183
10 Fate of Antibody-Drug Conjugates in Cancer Cells (10.1186/s13046-017-0667-1)
Abstract ORCID License
169.68 182
11 HIF-1α promoted vasculogenic mimicry formation in hepatocell… (10.1186/s13046-017-0533-1)
Abstract ORCID License
169.15 179
12 Long noncoding RNA NEAT1 promotes laryngeal squamous cell ca… (10.1186/s13046-016-0297-z)
Abstract ORCID License
167.66 171
13 Apoptosis in cancer: from pathogenesis to treatment (10.1186/1756-9966-30-87)
Abstract ORCID
167.32 2219
14 Tumor-associated macrophages correlate with the clinicopatho… (10.1186/s13046-015-0281-z)
Abstract ORCID License
166.51 165
15 Circular RNAs: emerging cancer biomarkers and targets (10.1186/s13046-017-0624-z)
Abstract ORCID License
164.90 157
16 Targeting microRNAs as key modulators of tumor immune respon… (10.1186/s13046-016-0375-2)
Abstract ORCID License
164.48 155
17 FGF19/FGFR4 signaling contributes to the resistance of hepat… (10.1186/s13046-016-0478-9)
Abstract ORCID License
164.27 154
18 Chrysin inhibited tumor glycolysis and induced apoptosis in… (10.1186/s13046-017-0514-4)
Abstract ORCID License
164.27 154
19 Sirtuins in metabolism, DNA repair and cancer (10.1186/s13046-016-0461-5)
Abstract ORCID License
164.06 153
20 14, 15-EET induces breast cancer cell EMT and cisplatin resi… (10.1186/s13046-018-0694-6)
Abstract ORCID License
163.85 152
21 The role of NLRP3 inflammasome in 5-fluorouracil resistance… (10.1186/s13046-017-0553-x)
Abstract ORCID License
163.42 150
22 Clinical implications of high NQO1 expression in breast canc… (10.1186/1756-9966-33-14)
Abstract ORCID License
162.99 148
23 Radiation-induced miR-208a increases the proliferation and r… (10.1186/s13046-016-0285-3)
Abstract ORCID License
162.99 148
24 Identification and validation of potential prognostic lncRNA… (10.1186/s13046-015-0219-5)
Abstract ORCID License
162.33 145
25 Multiple functions of hypoxia-regulated miR-210 in cancer (10.1186/1756-9966-33-50)
Abstract ORCID License
161.65 142
26 Cancer cells increase endothelial cell tube formation and su… (10.1186/s13046-017-0495-3)
Abstract ORCID License
161.65 142
27 Exosomes derived from HCC cells induce sorafenib resistance… (10.1186/s13046-016-0430-z)
Abstract ORCID License
161.42 141
28 CDK9 inhibitors in acute myeloid leukemia (10.1186/s13046-018-0704-8)
Abstract ORCID License
160.73 138
29 Molecular targeted therapy for the treatment of gastric canc… (10.1186/s13046-015-0276-9)
Abstract ORCID License
160.25 136
30 Intermittent high dose proton pump inhibitor enhances the an… (10.1186/s13046-015-0194-x)
Abstract ORCID License
159.78 134
31 Yin Yang 1 is associated with cancer stem cell transcription… (10.1186/s13046-016-0359-2)
Abstract ORCID License
159.78 134
32 Curcumin: the spicy modulator of breast carcinogenesis (10.1186/s13046-017-0566-5)
Abstract ORCID License
158.80 130
33 Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12… (10.1186/s13046-016-0486-9)
Abstract ORCID License
158.55 129
34 Notch signaling plays a crucial role in cancer stem-like cel… (10.1186/s13046-017-0507-3)
Abstract ORCID License
157.79 126
35 TFAP2C promotes stemness and chemotherapeutic resistance in… (10.1186/s13046-018-0683-9)
Abstract ORCID License
157.01 123
36 Deletion of interleukin-6 in monocytes/macrophages suppresse… (10.1186/s13046-016-0412-1)
Abstract ORCID License
156.74 122
37 LRG1 modulates epithelial-mesenchymal transition and angioge… (10.1186/s13046-016-0306-2)
Abstract ORCID License
156.48 121
38 The long non-coding RNA TP73-AS1 modulates HCC cell prolifer… (10.1186/s13046-017-0519-z)
Abstract ORCID License
154.27 113
39 Blockage of glycolysis by targeting PFKFB3 suppresses tumor… (10.1186/s13046-016-0481-1)
Abstract ORCID License
153.98 112
40 Arsenic trioxide induces oxidative stress, DNA damage, and m… (10.1186/1756-9966-33-42)
Abstract ORCID License
153.69 111
41 MicroRNA-381 inhibits the metastasis of gastric cancer by ta… (10.1186/s13046-017-0499-z)
Abstract ORCID License
153.69 111
42 A fresh look at zebrafish from the perspective of cancer res… (10.1186/s13046-015-0196-8)
Abstract ORCID License
153.10 109
43 The multiple facets of drug resistance: one history, differe… (10.1186/1756-9966-33-37)
Abstract ORCID License
152.81 108
44 Aquaporin 3 promotes epithelial-mesenchymal transition in ga… (10.1186/1756-9966-33-38)
Abstract ORCID License
152.81 108
45 Current concepts in bone metastasis, contemporary therapeuti… (10.1186/s13046-017-0578-1)
Abstract ORCID License
152.51 107
46 MiR-137 and miR-34a directly target Snail and inhibit EMT, i… (10.1186/s13046-016-0415-y)
Abstract ORCID License
151.90 105
47 Regulation of microRNAs by epigenetics and their interplay i… (10.1186/1756-9966-32-96)
Abstract ORCID License
151.59 104
48 Use of poly ADP-ribose polymerase [PARP] inhibitors in cance… (10.1186/s13046-016-0456-2)
Abstract ORCID License
151.59 104
49 Long non-coding RNA ATB promotes glioma malignancy by negati… (10.1186/s13046-016-0367-2)
Abstract ORCID License
150.65 101
50 Blockade of TIM3 relieves immunosuppression through reducing… (10.1186/s13046-018-0713-7)
Abstract ORCID License
150.65 101